Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2008-12-15 Delisting Announcement
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
FORM 15
Delisting Announcement Classification · 95% confidence The document is a Form 15 filed with the SEC, which is a certification and notice of termination of registration under Section 12(g) of the Securities Exchange Act of 1934 or suspension of duty to file reports under Sections 13 and 15(d). This form is used to notify the SEC and the public that the company is terminating its registration and thus delisting from reporting requirements. The document is short (2345 characters) and is a regulatory filing form, not a full report or announcement of a report. It is not an announcement of a report publication but an official regulatory filing related to delisting or suspension of reporting duties. Therefore, the most appropriate classification is Delisting Announcement (DLST).
2008-12-15 English
FORM 4
Director's Dealing
2008-12-13 English
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text specifically mentions the company's intention to voluntarily delist from the American Stock Exchange and suspend its reporting obligations. The document includes a press release as an exhibit but does not contain detailed financial statements or comprehensive reports. The length is short (2352 characters), and the content is an announcement of a delisting event. According to the filing definitions, an official notice that the company's stock will be removed from an exchange is classified as a Delisting Announcement (DLST).
2008-12-05 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a press release about a workforce reduction and operational changes, attached as an exhibit. There are no financial statements or detailed financial data included, and the document is relatively short (2516 characters). It is primarily an announcement of an event rather than a detailed financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2008-12-02 English
FORM 10-Q
Interim / Quarterly Report 9M 2008
2008-11-10 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content includes a press release about receiving an Office Action from the U.S. Patent and Trademark Office rejecting patent claims. The document is short (2462 characters) and primarily serves as an announcement of this event, including the press release as an exhibit. There are no financial statements, detailed financial data, or management discussion. It is not an annual or quarterly report, nor a detailed earnings release or investor presentation. It is a regulatory announcement of a material event, fitting the category of Regulatory Filings (RNS).
2008-11-03 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.